Acceleron Pharma Inc. (XLRN)
NASDAQ: XLRN
· Real-Time Price · USD
178.75
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM
Acceleron Pharma Revenue
Acceleron Pharma reported an annual revenue of $92.52M, reflecting a 25.04% growth. For the quarter ending September 30, 2021, Acceleron Pharma generated $34.2M in revenue.
Revenue (ttm)
92.52M
Revenue Growth
25.04%
Price / Sales Ratio
78.54
Revenue / Employee
296.55K
Employees
312
Market Cap
0
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2020 | 92.52M | +25.04% |
| Dec 31, 2019 | 73.99M | +428.86% |
| Dec 31, 2018 | 13.99M | +3.78% |
| Dec 31, 2017 | 13.48M | -51.46% |
| Dec 31, 2016 | 27.77M | +53.46% |
| Dec 31, 2015 | 18.1M | +23.68% |
| Dec 31, 2014 | 14.63M | -74.43% |
| Dec 31, 2013 | 57.23M | +275.18% |
| Dec 31, 2012 | 15.25M | -81.15% |
| Dec 31, 2011 | 80.91M | n/a |